Evaluating lipid-lowering drug targets for full-course diabetic retinopathy.
Cao J, Su T, Chen S, Du Z, Lai C, Chi K, Li Q, Wang S, Wu Q, Hu Y, Fang Y, Hu Y, Zhu Z, Huang Y, Zhang X, Yu H.
Cao J, et al.
Br J Ophthalmol. 2025 Feb 3:bjo-2024-325771. doi: 10.1136/bjo-2024-325771. Online ahead of print.
Br J Ophthalmol. 2025.
PMID: 39900481